- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 21.10. | Cellyan Biotechnology announces 1-for-20 reverse stock split | 1 | Seeking Alpha | ||
| 21.10. | Cellyan Biotechnology Co., Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 21.10. | Cellyan Biotechnology Announces a 1-for-20 Reverse Stock Split | - | GlobeNewswire (USA) | ||
| CELLYAN BIOTECHNOLOGY Aktie jetzt für 0€ handeln | |||||
| 23.09. | Cellyan Biotechnology Co., Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 10.09. | Cellyan Biotechnology Co., Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 07.08. | Cellyan Biotechnology Co., Ltd - 20-F, Annual and transition report of foreign private issuers | 2 | SEC Filings | ||
| 17.07. | Cellyan Biotechnology Stock Sinks 21% After Hours: Here's What Happened | 1 | Benzinga.com | ||
| 16.07. | Cellyan Biotechnology erhält 180-tägige Fristverlängerung für Nasdaq-Compliance | 1 | Investing.com Deutsch | ||
| 16.07. | Cellyan Biotechnology gets 180-day extension for Nasdaq compliance | 1 | Investing.com | ||
| 16.07. | Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Additional Compliance Grace Period | 258 | GlobeNewswire (Europe) | HONG KONG, July 16, 2026 (GLOBE NEWSWIRE) -- Cellyan Biotechnology Co., Ltd (Nasdaq: HKPD) (the "Company"), a leading provider of over the counter ("OTC") pharmaceutical cross-border e-commerce supply... ► Artikel lesen | |
| 16.07. | Cellyan Biotechnology Co., Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 16.01. | Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price Deficiency | 342 | GlobeNewswire (Europe) | HONG KONG, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Cellyan Biotechnology Co., Ltd (Nasdaq: HKPD) (the "Company"), a leading provider of over the counter ("OTC") pharmaceutical cross-border e-commerce supply... ► Artikel lesen | |
| 17.12.25 | Hong Kong Pharma Digital Technology Holdings Limited Announced Results of 2025 Annual Meeting of Stockholders | 1.807 | GlobeNewswire (Europe) | HONG KONG, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ: HKPD) ("HKPD" or the "Company"), a leading provider of over the counter ("OTC") pharmaceutical... ► Artikel lesen |
13 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 50,02 | +5,46 % | Aktien Frankfurt Ausblick: Dax stabilisiert sich | FRANKFURT (dpa-AFX) - Der Dax steuert nach der schwachen Vorwoche am Montag auf eine Stabilisierung zu. Eine Stunde vor Handelsbeginn signalisierte der X-Dax für den deutschen Leitindex ein Plus von... ► Artikel lesen | |
| GSK | 21,880 | +2,35 % | JPMORGAN stuft GSK auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für GSK auf "Underweight" mit einem Kursziel von 1700 Pence belassen. Die Studiendaten von Mocertatug Rezetecan (Mo-Rez) seien ermutigend... ► Artikel lesen | |
| QUANTUM BIOPHARMA | 2,064 | +4,24 % | Quantum BioPharma Signs Contract with Thermo Fisher Scientific's Clinical Research Business to Implement Phase 2 Lucid-MS Trial in Multiple Sclerosis | TORONTO, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (FRA: 0K91) ("Quantum BioPharma"), a biopharmaceutical company focused on developing innovative therapies and technologies... ► Artikel lesen | |
| SELLAS LIFE SCIENCES | 7,880 | -9,01 % | Sellas Life Sciences Group: 8-K nach Preclinical-Daten - was hinter dem Schub steckt | ||
| JAGUAR HEALTH | 0,884 | 0,00 % | Jaguar Health, Inc.: CSO of Napo Pharmaceuticals, a Jaguar Health Family Company, and Clinical Investigators Evaluating Crofelemer Conduct Panel Discussion at Pediatric Gastroenterology Conference in Dubai | Company remains sharply focused on its ongoing rare disease intestinal failure global development program for microvillus inclusion disease (MVID) and short bowel syndrome (SBS-IF) for crofelemer powder... ► Artikel lesen | |
| LIPOCINE | 1,440 | -0,69 % | Lipocine Inc.: Lipocine Announces Initiation of BLOOM Phase 3 Study of LPCN 1154 for Postpartum Depression | Study informed by encouraging exploratory efficacy findings and a favorable safety profile in the prior Phase 3 trial
Approximately 120 participants with severe... ► Artikel lesen | |
| THERAPEUTICSMD | 1,550 | -1,90 % | TherapeuticsMD, Inc. - 10-Q, Quarterly Report | ||
| ALLARITY THERAPEUTICS | 0,978 | 0,00 % | Allarity Therapeutics, Inc. - 8-K, Current Report | ||
| EXICURE | 0,885 | -1,67 % | Exicure, Inc.: Exicure to Settle GPCR Therapeutics Clinical Milestone Payment Through Equity Issuance | WILMINGTON, Del., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Exicure, Inc. (Nasdaq: XCUR) ("Exicure" or the "Company") today announced that it expects to issue 172,058 shares of its common stock to GPCR Therapeutics... ► Artikel lesen | |
| COSMOS HEALTH | 0,282 | +2,47 % | Cosmos Health Inc.: Cosmos Health's U.S. Active Subscriptions Surpass 12,000, Up 92% in Two Weeks | Active subscriptions up 92%: 12,050 active U.S. subscriptions as of October 28, 2026, up from 6,287 on October 14, 2026Monthly subscription value up 94%: $1,787,585 at standard renewal pricing as of... ► Artikel lesen | |
| 60 DEGREES PHARMACEUTICALS | 0,898 | 0,00 % | 60 Degrees Pharmaceuticals Announces Partnership with The University of Southern Mississippi to Evaluate Castanospermine in Nonclinical Models of Alpha-Gal Syndrome | ||
| SUNSHINE BIOPHARMA | 2,730 | 0,00 % | Sunshine Biopharma Inc.: Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing | FORT LAUDERDALE, FL / ACCESS Newswire / October 22, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company specializing in generic and specialty prescription medications... ► Artikel lesen | |
| SHUTTLE PHARMACEUTICALS | 4,950 | -6,60 % | Shuttle Pharmaceuticals Holdings Inc.: United Dogecoin Purchases Dogecoin Miners and Secures Renewable Energy Data Centre Site | Gaithersburg, Maryland--(Newsfile Corp. - June 26, 2026) - United Dogecoin Inc. ("United Dogecoin" or the "Company"), a Dogecoin mining company driven by industry experts recently acquired by Shuttle... ► Artikel lesen | |
| TEVA PHARMACEUTICAL INDUSTRIES | 40,640 | 0,00 % | Teva To Discontinue TOPAS-MSA Study In Adults With Multiple System Atrophy | PETAH TIKVA (dpa-AFX) - Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries (TEVA),
announced that it will discontinue the Phase 2 TOPAS-MSA study evaluating emrusolmin... ► Artikel lesen | |
| MERCK KGAA | 150,00 | +0,67 % | BARCLAYS stuft MERCK KGAA auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Merck KGaA von 150 auf 160 Euro angehoben, aber die Einstufung auf "Equal Weight" belassen. Analyst Charles Pitman-King... ► Artikel lesen |
Das Unternehmen CELLYAN BIOTECHNOLOGY CO LTD kann der Branche Pharma zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 1,910 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CELLYAN BIOTECHNOLOGY CO LTD finden Sie auf Wallstreet Online.